Ren et al. XG005, compound with NSAID and neuropathic like effects, in knee OA. At week 4 significant improvements in WOMAC pain, stiffness, function, and primary endpoint of walking pain @RheumNow #ACR24 Abstr#L08 https://t.co/gQDwAmzI4G https://t.co/b22XC7rXnE
Links:
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-ranging and Para…
https://acrabstracts.org/abstract/a-phase-2b-randomized-double-blind-placebo-co…
18-11-2024